Skip to content

Effect of anti-rheumatic drug calendar on methotrexate adherence

Effect of anti-rheumatic drug calendar on methotrexate adherence

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076228
Enrollment
Unknown
Registered
2023-09-27
Start date
2023-10-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatoid arthritis

Interventions

intervention group:An antirheumatic drug calendar card is used+Drug education
control group:Drug education

Sponsors

Ningbo Sixth Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients who took methotrexate tablets for the first time or needed to take methotrexate again more than three months after discontinuation of methotrexate tablets.

Exclusion criteria

Exclusion criteria: Patients who are delirious and unable to take medication on their own.

Design outcomes

Primary

MeasureTime frame
Proportion of Days Covered;The rate of return visit;The rate of incorrect intake;

Secondary

MeasureTime frame
The rate of adverse reactions;

Countries

China

Contacts

Public ContactFangfang Yuan

Ningbo Sixth Hospital

fangfangy20202020@163.com+86 158 8844 7607

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026